[Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis].
Hikita
Atsuhiko
A
Department of Orthopaedic Surgery, The University of Tokyo.
Tanaka
Sakae
S
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000473:pathology*; D001842:Bone and Bones / Q000473:pathology*; D002352:Carrier Proteins / Q000502:physiology; D002356:Cartilage / Q000473:pathology*; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D008562:Membrane Glycoproteins / Q000502:physiology; D010010:Osteoclasts / Q000166:cytology*; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D013583:Synovial Membrane / Q000166:cytology; D013601:T-Lymphocytes / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D002352:Carrier Proteins; D007375:Interleukin-1; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; D014409:Tumor Necrosis Factor-alpha